Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) Return on Assets: 2016-2025

Historic Return on Assets for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to -0.80%.

  • AC Immune's Return on Assets fell 64.00% to -0.80% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.80%, marking a year-over-year decrease of 64.00%. This contributed to the annual value of -0.25% for FY2024, which is 6.00% up from last year.
  • Latest data reveals that AC Immune reported Return on Assets of -0.80% as of Q3 2025, which was down 57.20% from -0.51% recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Return on Assets peaked at -0.00% during Q2 2021, and registered a low of -0.80% during Q3 2025.
  • Moreover, its 3-year median value for Return on Assets was -0.40% (2023), whereas its average is -0.41%.
  • In the last 5 years, AC Immune's Return on Assets rose by 28bps in 2024 and then slumped by 64bps in 2025.
  • Quarterly analysis of 5 years shows AC Immune's Return on Assets stood at -0.00% in 2021, then slumped by 37bps to -0.37% in 2022, then grew by 4bps to -0.33% in 2023, then declined by 8bps to -0.41% in 2024, then crashed by 64bps to -0.80% in 2025.
  • Its Return on Assets was -0.80% in Q3 2025, compared to -0.51% in Q2 2025 and -0.51% in Q1 2025.